Discontinued Operations and Divestitures (Tables)

3 Months Ended

Mar. 30, 2018

Schedule of Income (Loss) from Discontinued Operations

The following table summarizes the financial results of the Nuclear Imaging business presented in the unaudited condensed consolidated statements of income:

	Three Months Ended
Major line items constituting income from discontinued operations	March 30, 2018		March 31, 2017
Net sales	$	—	$	31.6
Cost of sales	—		15.6
Selling, general and administrative expenses	—		7.8
Other	—		(0.2		)
Income from discontinued operations	—		8.4
Gain on divestiture of discontinued operations	—		369.3
Income from discontinued operations, before income taxes	—		377.7
Income tax expense	—		5.4
Income from discontinued operations, net of income taxes	$	—	$	372.3

Schedule of Major Classes of Assets and Liabiltiies Held For Sale

.

Schedule of Significant Cash and Non-Cash Transactions

The following table summarizes significant cash and non-cash transactions of the Nuclear Imaging business that are included within the unaudited condensed consolidated statements of cash flows for the respective periods:

	Three Months Ended
	March 30, 2018		March 31, 2017
Depreciation	$	—	$	—
Capital expenditures	—		0.3

Specialty Generics Disposal Group

Schedule of Income (Loss) from Discontinued Operations

The following table summarizes the financial results of the Specialty Generics Disposal Group presented in the unaudited condensed consolidated statements of income:

	Three Months Ended
Major line items constituting income from discontinued operations	March 30, 2018		March 31, 2017
Net sales	$	182.7	$	250.9
Cost of sales	112.0		131.2
Selling, general and administrative expenses	18.8		21.1
Research and development cost	17.9		16.8
Restructuring charges, net	5.1		6.9
Other income, net	—		1.4
Income from discontinued operations	28.9		76.3
Income tax expense	6.8		2.5
Income from discontinued operations, net of income taxes	$	22.1	$	73.8

Schedule of Major Classes of Assets and Liabiltiies Held For Sale

The following table summarizes the assets and liabilities of the Specialty Generics Disposal Group that are classified as held for sale on the unaudited condensed consolidated balance sheets:

	March 30, 2018		December 29, 2017
Carrying amounts of major classes of assets included as part of discontinued operations
Accounts receivable	$	183.3	$	170.4
Inventories	212.8		211.7
Property, plant and equipment, net	551.2		553.6
Intangible assets, net	112.3		114.0
Other current and non-current assets	83.4		84.5
Total assets classified as held for sale in the balance sheet	$	1,143.0	$	1,134.2
Carrying amounts of major classes of liabilities included as part of discontinued operations
Accounts payable	$	40.6	$	36.0
Other current and non-current liabilities	119.1		126.6
Total liabilities classified as held for sale in the balance sheet	$	159.7	$	162.6

Schedule of Significant Cash and Non-Cash Transactions

The following table summarizes significant cash and non-cash transactions of the Specialty Generics Disposal Group that are included within the unaudited condensed consolidated statements of cash flows for the respective periods:

	Three Months Ended
	March 30, 2018		March 31, 2017
Depreciation	$	8.9	$	15.5
Amortization	1.7		5.3
Capital expenditures	8.7		16.3